1
Published 2014
Canadian Agency for Drugs and Technologies in Health
Subjects: ...Naloxone / administration & dosage...

2
Published 2016
Canadian Agency for Drugs and Technologies in Health
Subjects: ...Buprenorphine, Naloxone Drug Combination / administration & dosage...

3
by Chao, Yi-Sheng, Loshak, Hannah
Published 2019
Canadian Agency for Drugs and Technologies in Health
...Administration of naloxone in a home or community setting...

4
by Chao, Yi-Sheng, Loshak, Hannah
Published 2019
Canadian Agency for Drugs and Technologies in Health
Subjects: ...Naloxone / therapeutic use...

5
by Brooker, Ann-Sylvia, Farrah, Kelly
Published 2019
CADTH
Subjects: ...Naloxone / therapeutic use...

6
Published 2014
Canadian Agency for Drugs and Technologies in Health
Subjects: ...Naloxone / administration & dosage...

7
Published 2016
Canadian Agency for Drugs and Technologies in Health
Subjects: ...Buprenorphine, Naloxone Drug Combination / administration & dosage...

8
by Brooker, Ann-Sylvia, Farrah, Kelly
Published 2019
CADTH
...This purpose of this report was to explore the experience of administering naloxone in the home...

9
by Campbell, Nancy D.
Published 2020
The MIT Press

10
Published 2016
Canadian Agency for Drugs and Technologies in Health
...In 2013, Suboxone (buprenorphine/naloxone) became available as a generic and its direct cost...

11
Published 2016
Canadian Agency for Drugs and Technologies in Health
Subjects: ...Buprenorphine, Naloxone Drug Combination...

12
by Peprah, Kwakye, Frey, Nina
Published 2017
Canadian Agency for Drugs and Technologies in Health
Subjects: ...Naloxone / administration & dosage...

13
by Peprah, Kwakye, Severn, Melissa
Published 2019
CADTH
... and delivery mechanisms of naloxone for the treatment of opioid poisoning in pre-hospital settiongs...

15
by Peprah, Kwakye, Frey, Nina
Published 2017
Canadian Agency for Drugs and Technologies in Health
... and cost effectiveness of the various formulations and delivery mechanisms of naloxone for the treatment...

16
by Chou, Roger
Published 2017
Agency for Healthcare Research and Quality (US)
Subjects: ...Naloxone / therapeutic use...

17
by Chou, Roger
Published 2017
Agency for Healthcare Research and Quality (US)
... concentration IN naloxone (2 mg/1 mL) is similar in efficacy to IM naloxone (2 mg), with no difference...

18
Published 2014
World Health Organization
Subjects: ...Naloxone / therapeutic use...

19
Published 2013
Canadian Agency for Drugs and Technologies in Health
Subjects: ...Naloxone / therapeutic use...

20
by Harricharan, Sharada, Farrah, Kelly
Published 2017
Canadian Agency for Drugs and Technologies in Health
Subjects: ...Buprenorphine, Naloxone Drug Combination / therapeutic use...